HOME ·

06996.HK

Antengene Corporation(06996.HK): ATG‑201 Receives HREC Approval in Australia for Phase I Clinical Trial
Tags：
Antengene Corporation06996.HK
2026-08-25
Antengene Corporation Limited (06996.HK): Expected to Swing to Profit in Interim Period, Revenue to Hit RMB 490 Million to RMB 536 Million
Tags：
Antengene Corporation Limited06996.HK
2026-07-28
Antengene Corporation(06996.HK): Plans Share Repurchase of Up to HK$50 Million
Tags：
Antengene Corporation06996.HK
2026-06-25
Antengene-B(06996.HK): Exclusive License Agreement Secured for ATG-106 with Potential Milestone Payments up to Approximately USD960.5 Million
Tags：
ANTENGENE-B06996.HKExclusive License
2026-06-22
Antengene-B (06996.HK) ：ATG-201 IND for Autoimmune Diseases Approved by China's NMPA
Tags：
ANTENGENE-B06996.HKinvestigational new drug
2026-06-10